GlobeNewswire (Thu, 7:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
156 people get RGDX articles and Market Currents by email alert.
Get email alerts on RGDX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
GlobeNewswire (Tue, 7:00AM)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 6, 2013)
-
GlobeNewswire (Mar 21, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
-
-
PR Newswire (Nov 29, 2012)
-
-
PR Newswire (Nov 13, 2012)
-
PR Newswire (Nov 5, 2012)
-
PR Newswire (Oct 8, 2012)
-
PR Newswire (Oct 1, 2012)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
Response Genetics: An Earnings PrimerAndrew Nava • Wed, May 12, 2010 -
-
GlobeNewswire (Thu, 7:00AM)
-
GlobeNewswire (Tue, 7:00AM)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 6, 2013)
-
GlobeNewswire (Mar 21, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
PR Newswire (Nov 29, 2012)
-
PR Newswire (Nov 13, 2012)
-
PR Newswire (Nov 5, 2012)
-
PR Newswire (Oct 8, 2012)
-
PR Newswire (Oct 1, 2012)
-
at MarketWatch.com (Sep 13, 2012)
-
PR Newswire (Sep 13, 2012)
-
PR Newswire (Aug 14, 2012)
-
Business Wire (Jun 28, 2012)
-
Business Wire (May 10, 2012)
RGDX vs. ETF Alternatives
Company Description
Currently, there's no company description for RGDX.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Thursday, May 16, 9:14 AM
Premarket gainers: RGDX +24%. EGLE +23%. EFUT +19%. TSLA +13%. CSCO +13%. SCTY +11%. DQ +9%. HALO +8%. DANG +7%. AV +7%. YRCW +8%. NBG +7%. KSS +7%. SPWR +6%.
Losers: NCT -53%. SNFCA -24%. AMD -10%. NQ -7%. CYCC -5%. Comment! [On the Move] - Thursday, May 16, 7:42 AM Response Genetics (RGDX) jumps 29.63% premarket after announcing an agreement to join all of Blue Shield of California's provider networks. This is the company's first Blue Cross Blue Shield contract. (PR) Comment! [On the Move, Healthcare]
- Tuesday, May 14, 9:15 AM Response Genetics (RGDX): Q1 EPS of -$0.03 beats by $0.01. Revenue of $5.6M (+40% Y/Y) beats by $0.7M. (PR) Comment! [Earnings, Healthcare]
- Thursday, March 21, 7:08 AM Response Genetics (RGDX): Q4 EPS of -$0.01 beats by $0.05. Revenue of $5.5M (+11% Y/Y) beats by $0.34M. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
Monday, March 18, 12:48 PM
Midday top 10 gainers: YRCW +25%. PRWT +22%. ULTR +17%. IG +17%. CHYR +16%. ATOS +14%. TA +13%. NYMX +13%. WILC +11%. SORL +11%.
Midday top 10 losers: AMBO -19%. PTX -12%. SOL -10%. CNET -10%. EMITF -9%. TSEM -8%. MNDO -8%. RGDX -8%. JVA -8%. AMBA -8%. 1 Comment [On the Move] - Tuesday, November 27, 2012, 12:45 PM Midday top 10 gainers: ACAD +141%. CPSL +30%. IMMR +30%. RAH +27%. TSPT +12%. BWEN +12%. CUR +12%. FOLD +10%. FONR +10%. CDTI +10%. Midday top 10 Losers: STV -11%. MMR -9%. THO -11%. RECV -10%. CBAK -9%. BLIN -12%. ENMD -8%. RGDX -8%. ARCI -8%. BV -8%. Comment!
- Tuesday, November 13, 2012, 6:34 AM Response Genetics (RGDX): Q3 EPS of -$0.07 in-line. Revenue of $5.4M beats by $0.9M. (PR) Comment! [Earnings, Healthcare]
- Thursday, September 13, 2012, 3:10 PM Response Genetics (RGDX +33.3%) ramps higher today after it announced earlier that it entered into a purchase agreement with GlaxoSmithKline (GSK +1.7%) and one of its existing significant stockholders to raise $8.8M from the private placement of 8M newly issued shares at $1.10 per share. Comment! [Healthcare, On the Move]
